Oruka Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Oruka Therapeutics, Inc. (ORKA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 100.81 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-10
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 22.85K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 77.97K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 8.75K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-06-30 was 32.79K shares, a 27.25% decline year-over-year.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 40.75K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 88.25K shares, a 65.95% decline from fiscal 2022.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 259.16K shares, a 326.15% increase from fiscal 2021.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 60.81K shares, a 24422.18% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 22.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 100.81K shares 10-Q · filed 2026-08-10 | 109.56K shares derived: sum of 3 quarters · filed 2026-08-10 | ||
| 2026-03-31 | 77.97K shares 10-Q · filed 2026-05-13 | 86.72K shares derived: sum of 2 quarters · filed 2026-05-13 | |||
| 2025-12-31 | 8.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 40.75K shares 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 32.00K shares 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | 32.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 45.65K shares 10-Q · filed 2024-08-01 | 45.73K shares derived: sum of 3 quarters · filed 2024-08-01 | 48.73K shares derived: sum of 4 quarters · filed 2024-08-01 | |
| 2024-03-31 | 12.86K shares 10-Q · filed 2024-04-25 | 12.94K shares derived: sum of 2 quarters · filed 2024-04-25 | 15.94K shares derived: sum of 3 quarters · filed 2024-04-25 | 61.01K shares derived: sum of 4 quarters · filed 2024-04-25 | |
| 2023-12-31 | 79.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | 3.08K shares derived: sum of 2 quarters · filed 2024-02-01 | 48.15K shares derived: sum of 3 quarters · filed 2024-02-01 | 88.25K shares 10-K · filed 2024-02-01 | |
| 2023-09-30 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | 48.07K shares derived: sum of 2 quarters · filed 2023-10-18 | 88.17K shares 10-Q · filed 2023-10-18 | 160.45K shares derived: sum of 4 quarters · filed 2024-02-01 | |
| 2023-06-30 | 45.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-21 | 85.18K shares 10-Q · filed 2023-07-21 | 157.45K shares derived: sum of 3 quarters · filed 2024-02-01 | 308.73K shares derived: sum of 4 quarters · filed 2024-02-01 | |
| 2023-03-31 | 40.10K shares 10-Q · filed 2023-04-24 | 112.38K shares derived: sum of 2 quarters · filed 2024-02-01 | 263.66K shares derived: sum of 3 quarters · filed 2024-02-01 | 264.60K shares derived: sum of 4 quarters · filed 2024-02-01 | |
| 2022-12-31 | 72.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | 223.56K shares derived: sum of 2 quarters · filed 2024-02-01 | 224.50K shares derived: sum of 3 quarters · filed 2024-02-01 | 259.16K shares 10-K · filed 2024-02-01 | |
| 2022-09-30 | 151.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | 152.23K shares derived: sum of 2 quarters · filed 2022-10-28 | 186.89K shares 10-Q · filed 2022-10-28 | 186.89K shares derived: sum of 4 quarters · filed 2023-02-24 | |
| 2022-06-30 | 945.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 35.61K shares 10-Q · filed 2022-08-02 | 35.61K shares derived: sum of 3 quarters · filed 2023-02-24 | 42.89K shares derived: sum of 4 quarters · filed 2023-02-24 | |
| 2022-03-31 | 34.66K shares 10-Q · filed 2022-05-02 | 34.66K shares derived: sum of 2 quarters · filed 2023-02-24 | 41.94K shares derived: sum of 3 quarters · filed 2023-02-24 | 93.54K shares derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | 7.28K shares derived: sum of 2 quarters · filed 2023-02-24 | 58.87K shares derived: sum of 3 quarters · filed 2023-02-24 | 60.81K shares 10-K · filed 2023-02-24 | |
| 2021-09-30 | 7.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 58.87K shares derived: sum of 2 quarters · filed 2021-11-02 | 60.81K shares 10-Q · filed 2021-11-02 | 60.81K shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-06-30 | 51.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 53.54K shares 10-Q · filed 2021-08-04 | 53.54K shares derived: sum of 3 quarters · filed 2022-03-14 | 53.54K shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2021-03-31 | 1.94K shares 10-Q · filed 2021-05-11 | 1.94K shares derived: sum of 2 quarters · filed 2022-03-14 | 1.94K shares derived: sum of 3 quarters · filed 2022-03-14 | 1.94K shares derived: sum of 4 quarters · filed 2022-03-14 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | 2.00 shares derived: sum of 2 quarters · filed 2022-03-14 | 2.00 shares derived: sum of 3 quarters · filed 2022-03-14 | 248.00 shares 10-K · filed 2022-03-14 | |
| 2020-09-30 | 2.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | 2.00 shares derived: sum of 2 quarters · filed 2020-11-02 | 248.00 shares 10-Q · filed 2020-11-02 | 1.79K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | 246.00 shares 10-Q · filed 2020-08-05 | 1.79K shares derived: sum of 3 quarters · filed 2021-03-18 | 1.94K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-03-31 | 246.00 shares 10-Q · filed 2020-05-06 | 1.79K shares derived: sum of 2 quarters · filed 2021-03-18 | 1.94K shares derived: sum of 3 quarters · filed 2021-03-18 | 2.39K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-12-31 | 1.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 1.70K shares derived: sum of 2 quarters · filed 2021-03-18 | 2.15K shares derived: sum of 3 quarters · filed 2021-03-18 | 2.37K shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 150.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 598.00 shares derived: sum of 2 quarters · filed 2019-11-06 | 820.00 shares 10-Q · filed 2019-11-06 | -44.23K shares derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-06-30 | 448.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 670.00 shares 10-Q · filed 2019-08-01 | -44.38K shares derived: sum of 3 quarters · filed 2020-02-18 | -23.25K shares derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-03-31 | 222.00 shares 10-Q · filed 2019-05-08 | -44.83K shares derived: sum of 2 quarters · filed 2020-02-18 | -23.70K shares derived: sum of 3 quarters · filed 2020-02-18 | -7.17K shares derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-12-31 | -45.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -23.92K shares derived: sum of 2 quarters · filed 2020-02-18 | -7.39K shares derived: sum of 3 quarters · filed 2020-02-18 | 2.65K shares 10-K · filed 2020-02-18 | 47.97K shares 10-K · filed 2019-02-27 |
| 2018-09-30 | 21.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 37.67K shares derived: sum of 2 quarters · filed 2018-11-14 | 47.71K shares 10-Q · filed 2018-11-14 | 256.32K shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-06-30 | 16.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 26.58K shares 10-Q · filed 2018-08-09 | 235.19K shares derived: sum of 3 quarters · filed 2019-02-27 | 236.23K shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-03-31 | 10.04K shares 10-Q · filed 2018-05-08 | 218.65K shares derived: sum of 2 quarters · filed 2019-02-27 | 219.69K shares derived: sum of 3 quarters · filed 2019-02-27 | 224.68K shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-12-31 | 208.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 209.65K shares derived: sum of 2 quarters · filed 2019-02-27 | 214.64K shares derived: sum of 3 quarters · filed 2019-02-27 | 487.25K shares 10-K · filed 2019-02-27 | |
| 2017-09-30 | 1.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 6.03K shares derived: sum of 2 quarters · filed 2017-11-09 | 278.64K shares 10-Q · filed 2017-11-09 | 279.28K shares derived: sum of 4 quarters · filed 2018-03-22 | |
| 2017-06-30 | 4.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 277.60K shares 10-Q · filed 2017-08-03 | 278.24K shares derived: sum of 3 quarters · filed 2018-03-22 | 278.24K shares derived: sum of 4 quarters · filed 2018-03-22 | |
| 2017-03-31 | 272.61K shares 10-Q · filed 2017-05-15 | 273.25K shares derived: sum of 2 quarters · filed 2018-03-22 | 273.25K shares derived: sum of 3 quarters · filed 2018-03-22 | 273.72K shares derived: sum of 4 quarters · filed 2018-03-22 | |
| 2016-12-31 | 636.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | 636.00 shares derived: sum of 2 quarters · filed 2018-03-22 | 1.11K shares derived: sum of 3 quarters · filed 2018-03-22 | 19.35K shares 10-K · filed 2018-03-22 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 476.00 shares derived: sum of 2 quarters · filed 2016-11-14 | 18.71K shares 10-Q · filed 2016-11-14 | 29.28K shares derived: sum of 4 quarters · filed 2017-03-21 | |
| 2016-06-30 | 476.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 18.71K shares 10-Q · filed 2016-08-09 | 29.28K shares derived: sum of 3 quarters · filed 2017-03-21 | 24.64K shares derived: sum of 4 quarters · filed 2017-03-21 | |
| 2016-03-31 | 18.24K shares 10-Q · filed 2016-05-11 | 28.80K shares derived: sum of 2 quarters · filed 2017-03-21 | 24.17K shares derived: sum of 3 quarters · filed 2017-03-21 | 30.85K shares derived: sum of 4 quarters · filed 2017-03-21 | |
| 2015-12-31 | 10.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | 5.93K shares derived: sum of 2 quarters · filed 2017-03-21 | 12.62K shares derived: sum of 3 quarters · filed 2017-03-21 | 12.80K shares 10-K · filed 2017-03-21 | |
| 2015-09-30 | -4.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 2.05K shares derived: sum of 2 quarters · filed 2015-11-12 | 2.23K shares 10-Q · filed 2015-11-12 | -782.00 shares derived: sum of 4 quarters · filed 2016-03-17 | |
| 2015-06-30 | 6.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 6.87K shares 10-Q · filed 2015-08-11 | 3.85K shares derived: sum of 3 quarters · filed 2016-03-17 | 3.85K shares derived: sum of 4 quarters · filed 2016-03-17 | |
| 2015-03-31 | 183.00 shares 10-Q · filed 2015-05-12 | -2.83K shares derived: sum of 2 quarters · filed 2016-03-17 | -2.83K shares derived: sum of 3 quarters · filed 2016-03-17 | 649.00 shares derived: sum of 4 quarters · filed 2016-03-17 | |
| 2014-12-31 | -3.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | -3.01K shares derived: sum of 2 quarters · filed 2016-03-17 | 466.00 shares derived: sum of 3 quarters · filed 2016-03-17 | 493.00 shares 10-K · filed 2016-03-17 | 3.51K shares 10-K · filed 2015-03-19 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 3.48K shares derived: sum of 2 quarters · filed 2014-11-12 | 3.51K shares 10-Q · filed 2014-11-12 | 84.73K shares derived: sum of 4 quarters · filed 2015-03-19 | |
| 2014-06-30 | 3.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | 3.51K shares 10-Q · filed 2014-08-13 | 84.73K shares derived: sum of 3 quarters · filed 2015-03-19 | 39.30K shares derived: sum of 4 quarters · filed 2015-03-19 | |
| 2014-03-31 | 27.00 shares 10-Q · filed 2014-05-13 | 81.25K shares derived: sum of 2 quarters · filed 2015-03-19 | 35.83K shares derived: sum of 3 quarters · filed 2015-03-19 | 35.88K shares derived: sum of 4 quarters · filed 2015-03-19 | |
| 2013-12-31 | 81.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | 35.80K shares derived: sum of 2 quarters · filed 2015-03-19 | 35.85K shares derived: sum of 3 quarters · filed 2015-03-19 | 42.11K shares 10-K · filed 2015-03-19 | |
| 2013-09-30 | -45.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -45.37K shares derived: sum of 2 quarters · filed 2013-11-13 | -39.11K shares 10-Q · filed 2013-11-13 | -9.97K shares derived: sum of 4 quarters · filed 2014-03-20 | |
| 2013-06-30 | 55.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | 6.31K shares 10-Q · filed 2013-08-13 | 35.45K shares derived: sum of 3 quarters · filed 2014-03-20 | -3.50K shares derived: sum of 4 quarters · filed 2014-03-20 | |
| 2013-03-31 | 6.26K shares 10-Q · filed 2013-05-13 | 35.40K shares derived: sum of 2 quarters · filed 2014-03-20 | -3.56K shares derived: sum of 3 quarters · filed 2014-03-20 | ||
| 2012-12-31 | 29.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -9.81K shares derived: sum of 2 quarters · filed 2014-03-20 | 5.85K shares 10-K · filed 2014-03-20 | ||
| 2012-09-30 | -38.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -23.29K shares 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | 15.67K shares 10-Q · filed 2012-08-13 | ||||
| 2011-12-31 | 42.10K shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |